BIO3 Stock Overview
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally.
Capture your thoughts, links and company narrative
Biotest Aktiengesellschaft Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€31.60|
|52 Week High||€36.40|
|52 Week Low||€29.60|
|1 Month Change||-0.63%|
|3 Month Change||-5.67%|
|1 Year Change||-11.73%|
|3 Year Change||55.67%|
|5 Year Change||26.15%|
|Change since IPO||401.40%|
Recent News & Updates
|BIO3||DE Biotechs||DE Market|
Return vs Industry: BIO3 underperformed the German Biotechs industry which returned -4.6% over the past year.
Return vs Market: BIO3 underperformed the German Market which returned -8.5% over the past year.
|BIO3 Average Weekly Movement||3.4%|
|Biotechs Industry Average Movement||6.7%|
|Market Average Movement||5.0%|
|10% most volatile stocks in DE Market||10.0%|
|10% least volatile stocks in DE Market||2.7%|
Stable Share Price: BIO3 is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: BIO3's weekly volatility (3%) has been stable over the past year.
About the Company
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas.
Biotest Aktiengesellschaft Fundamentals Summary
|BIO3 fundamental statistics|
Is BIO3 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BIO3 income statement (TTM)|
|Cost of Revenue||€394.00m|
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 10, 2023
|Earnings per share (EPS)||-1.19|
|Net Profit Margin||-9.12%|
How did BIO3 perform over the long term?See historical performance and comparison